Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Antibody-Drug Conjugate for Treating Leukemia and Lymphoma-The Present Status, Problems, and Future Development]. | Gan To Kagaku Ryoho | 2024 | 39191681 | PubTator, text mining | PubMed |
| Clinicopathological and Molecular Characteristics of Rare EBV-associated Diffuse Large B-cell Lymphoma With IRF4 Rearrangement. | Am J Surg Pathol | 2024 | 39172106 | PubTator, text mining | PubMed |
| A comparison of scRNA-seq annotation methods based on experimentally labeled immune cell subtype dataset. | Brief Bioinform | 2024 | 39120646 | PubTator, text mining | PubMed |
| Control of germinal center B cell survival and IgE production by an adaptor molecule containing PH and SH2 domains, Aps/Sh2b2. | Sci Rep | 2024 | 39090233 | PubTator, text mining | PubMed |
| The Evolving Role of Bispecific Antibodies in Diffuse Large B-Cell Lymphoma. | J Pers Med | 2024 | 39063920 | PubTator, text mining | PubMed |
| Plasma circulating tumour DNA is a better source for diagnosis and mutational analysis of IVLBCL than tissue DNA. | J Cell Mol Med | 2024 | 39054569 | PubTator, text mining | PubMed |
| Method for B Cell Receptor Enrichment in Malignant B Cells. | Cancers (Basel) | 2024 | 39001403 | PubTator, text mining | PubMed |
| Comparative single-cell transcriptional and proteomic atlas of clinical-grade injectable mesenchymal source tissues. | Sci Adv | 2024 | 38996032 | PubTator, text mining | PubMed |
| A real-world pharmacovigilance study of polatuzumab vedotin based on the FDA adverse event reporting system (FAERS). | Front Pharmacol | 2024 | 38983914 | PubTator, text mining | PubMed |
| Cytoplasmic Lipid Droplets Predict Worse Prognosis in Diffuse Large B-Cell Lymphoma: Next-Generation Sequencing Deciphering Lipogenic Genes. | Am J Surg Pathol | 2024 | 38979928 | PubTator, text mining | PubMed |
| Multiomics analysis of IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylation. | Blood | 2024 | 38968152 | PubTator, text mining | PubMed |
| ezSingleCell: an integrated one-stop single-cell and spatial omics analysis platform for bench scientists. | Nat Commun | 2024 | 38961061 | PubTator, text mining | PubMed |
| Clinical and Genomic Profile of Primary Cranial Neurolymphomatosis. | J Blood Med | 2024 | 38947230 | PubTator, text mining | PubMed |
| Comparative Study on the Clinicopathologic and Molecular Characteristics of Primary and Secondary Diffuse Large B-cell Lymphoma in the Central Nervous System. | Anticancer Res | 2024 | 38925823 | PubTator, text mining | PubMed |
| Diagnostic potential of vitreoretinal lymphoma by detection of gene mutations with NGS in 25 Chinese patients. | Clin Chim Acta | 2024 | 38909978 | PubTator, text mining | PubMed |
| Transformation of t(14;18)-negative follicular lymphoma to plasmablastic lymphoma: a case report with analysis of genetic evolution. | Diagn Pathol | 2024 | 38909266 | PubTator, text mining | PubMed |
| Impact of genetic alterations on central nervous system progression of primary vitreoretinal lymphoma. | Haematologica | 2024 | 38841798 | PubTator, text mining | PubMed |
| A hybrid demultiplexing strategy that improves performance and robustness of cell hashing. | Brief Bioinform | 2024 | 38828640 | PubTator, text mining | PubMed |
| Spotlight on polatuzumab vedotin: new standards for diffuse large B-cell lymphoma? | Haematologica | 2024 | 38813707 | PubTator, text mining | PubMed |
| Fluoxetine Successfully Treats Intracranial Enterovirus E18 Infection in a Patient with CD79a Deficiency Arising from Segmental Uniparental Disomy of Chromosome 19. | J Clin Immunol | 2024 | 38805163 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=13